At Masten Research, cancer therapies are fundamentally applied through MST-335 immunomodulation, gene therapy, and DNA modulation methods. Gene therapy is a method that involves editing genes in human cells or preventing diseases. The goal is to transfer suitable genes in place of mutated or disease-causing ones.

Masten Research applies MST-335 immunomodulation, gene therapy, and DNA modulation methods as the foundation of cancer therapies. Gene therapy aims to edit genes in human cells or prevent diseases. It targets the transfer of suitable genes to replace those that are mutated or cause disease.
Gene therapy is the use of DNA segments (usually genes) in the treatment or prevention of genetic diseases. It requires the transfection of plasmids containing transgenes into target cells via viral or non-viral vectors14. Gene therapy is a promising method for many diseases such as thalassemia, SCID, hemophilia, cystic fibrosis, hereditary blindness, cancer, HIV, Parkinson’s, and more1.
DNA modulation is a method used to change the structure or function of DNA. It includes various techniques such as gene editing, epigenetic modification, DNA damage and repair, DNA methylation, and DNA recombination. DNA modulation can be used in the diagnosis, treatment, or prevention of genetic diseases, control of gene expression, cell differentiation, tissue engineering, biotechnology, and forensics.